Ultrasound in the (premotor) diagnosis of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. 3, 2007, Pages

  Berg, Daniela ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Differential diagnosis of Parkinsonian syndromes; Premotor marker; Substantia nigra hyperechogenicity; Transcranial sonography; vulnerability of the nigrostriatal system

Indexed keywords

IRON;

ARTICLE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; ECHOENCEPHALOGRAPHY; HUMAN; HYPOTHESIS; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PREMOTOR CORTEX; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SYMPTOM;

BRAIN; HUMANS; PARKINSON DISEASE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 38949175406     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(08)70043-9     Document Type: Article

References (20)

1. Berg D., Behnke S., and Walter U. Application of transcranial sonography in extrapyramidal disorders: Updated recommendations. Ultraschall Med 27 (2006) 12-19
2. Berg D., Siefker C., and Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 8 (2001) 684-689
3. Walter U., Wittstock M., Benecke R., and Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 109 (2002) 191-196
4. Prestel J., Schweitzer K., Hofer A., Gasser T., and Berg D. Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Mov Disord 21 (2006) 1763-1765
5. Becker G., Berg D., Lesch K., and Becker T. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol 4 (2001) 21-31
6. Walter U., Dressler D., Wolters A., Wittstock M., and Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 22 (2007) 48-54
7. Stockner H., Sojer M., Seppi K., Mueller J., Wenning G., Schmidauer C., et al. Midbrain sonography in patients with essential tremor. Mov Disord 22 (2007) 414-417
8. Behnke S., Berg D., Naumann M., and Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76 (2005) 423-425
9. Walter U., Niehaus L., Probst T., Benecke R., Meyer B., and Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60 (2003) 74-77
10. Gaenslen A., Unmuth B., Liepelt I., Di Santo A., Schweitzer K., Godau J., et al. Specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease. Mov Disord 22 Suppl 16 (2007) 102
11. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53 (1999) 1026-1031
12. Berg D., Roggendorf W., Schroder U., Klein R., Tatschner T., Benz P., et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59 (2002) 999-1005
13. Berg D., Siefker C., Ruprecht-Dorfler P., and Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56 (2001) 13-17
14. Berg D., Jabs B., Merschdorf U., Beckmann H., and Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50 (2001) 463-467
15. Walter U., Klein C., Hilker R., Benecke R., Pramstaller P., and Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19 (2004) 1445-1449
16. Ruprecht-Dorfler P., Klotz P., Becker G., and Berg D. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat Disord 6 (2007) 362-364
17. Sommer U., Hummel T., Cormann K., Mueller A., Frasnelli J., Kropp J., et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19 (2004) 1196-1202
18. Schweitzer K., Behnke S., Liepelt I., Wolf B., Grosser C., and Godau J. Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J Neural Transm 114 (2007) 1167-1171
19. Iova A., Garmashov A., Andruchtchenko N., Kehrer M., Berg D., Becker G., et al. Postnatal decrease in substantia nigra echogenicity - Implications for the pathogenesis of Parkinson's disease. J Neurol 251 (2004) 1451-1454
20. Berg D., Hochstrasser H., Schweitzer K., and Riess O. Disturbance of iron metabolism in Parkinson's disease - Ultrasonography as a biomarker. Neurotox Res 9 (2006) 1-13